We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
277 hedge funds and large institutions have $2.09B invested in Amphastar Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 97 increasing their positions, 93 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
100% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 24
53% more call options, than puts
Call options by funds: $3.35M | Put options by funds: $2.18M
42% more capital invested
Capital invested by funds: $1.47B → $2.09B (+$623M)
8% more funds holding
Funds holding: 256 → 277 (+21)
5.19% more ownership
Funds ownership: 65.5% → 70.69% (+5.2%)
4% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 93
Holders
277
Holders Change
+21
Holders Change %
+8.2%
% of All Funds
4.04%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
48
Increased
97
Reduced
93
Closed
24
Calls
$3.35M
Puts
$2.18M
Net Calls
+$1.16M
Net Calls Change
+$1.1M
Top Buyers
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$34.1M |
| 2 |
Morgan Stanley
New York
|
+$30.7M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$24.2M |
| 4 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$21M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$11.2M |
Top Sellers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$28.8M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$18.2M |
| 3 |
Goldman Sachs
New York
|
-$9.64M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.9M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$8.62M |
